¶ Indiana Biosciences Research Institute (IBRI) |
 |
|
| 1210 Waterway Blvd., Ste. 2000, Indianapolis, IN 46202 www.indianabiosciences.org Twitter: @INBiosciences |
Nonprofit | |
| Role(s) | • The IBRI is an independent, discovery science, and applied research institute currently targeting diabetes, metabolic disease, poor nutrition, and related health data science. • The IBRI exists to bring together companies and universities to work collaboratively on interrelated health issues that are of both global significance and have a disproportionate impact on Hoosiers. |
|
| Mission | To become the leading independent, industry-inspired applied research institute in the discovery and development of innovative solutions to improve health, targeting diabetes, metabolic disease, and poor nutrition. | |
| Key Events | 2012 – Indiana state, civic, corporate, and academic leaders called for creating an independent applied research institute 2015 – The IBRI finds its temporary home in the BRTC and starts staffing 2016 – Additional funding provided through Lilly Endowment and matching funds 2018 – The IBRI aligns around three centers: The IBRI Diabetes Center, (IDC) The Applied Data Sciences Center (ADSC), and The Pharmaceutical Biotechnology Center (PBC) 2020 – IBRI moves to permanent home in Building One in 16Tech Innovation District |
|
| Org | Approximately 35 (2019) split into multiple centers and principle investigator CEO search underway Leadership: • Alan Palkowitz: President and CEO • Jay McGill: Chief Operating Officer |
|
| Board | The IBRI has board membership that spans its stakeholder organizations: • Dan Evans, Chairman, Former CEO, IU Health • Dr, Kristina Box, ISDH Commissioner • Wayne Burris, Former SVP & CFO, Roche Diagnostics • John C. Lechleiter, PhD, Former CEO, Eli Lilly and Company • Dan Peterson, VP, Cook Group Inc. • Bill Stephan, VP, Indiana University • Jon Serbousek, Mid-Tech Industry Advisor • Patricia Martin, Pres. & CEO, BioCrossroads, Inc. |
|
| Finance | • $50M funding commitment from State + Industry matching funds (2014) • $100M from Lilly Endowment and Lilly Foundation (2016) • $20M State Funds (2017) • IBRI Foundation holds key funding ($126M – 2018 Form 990) |
|
| Data | • Limited IBRI specific data sources – although growing in the IBRI Diabetes Center • Applied Data Sciences Center (ADSC) works through data use agreements with partner organizations based on problem space • Public Data Repository at https://data.indianabiosciences.org |
|
| Access | • All data access and collaborations are performed with appropriate Research Agreements, IRBs, and DUAs in place. • The IBRI facility is designed to be an open collaborative environment facilitating research and innovation across industrial, academic, government, entrepreneurial, and other nonprofits. • Security processes and measures in place to facilitate secure access and collaboration. |
|
| Tech Capabilities | • Secure-cloud based (vendor-agnostic) technologies in place to facilitate secure collaborations. • Expertise at defining applied problems and driving implementation across data and technology to support applied multi-organizational collaborations. • Skills, software, expertise, and software for working across and integrating multiple types of data: EHR, deep biology, socio-economic, and electronic data. |
|
| Projects | • ISDH Diabetes Strategy (Regenstrief Institute-MPH-IHIE-IBRI) • Corteva-Lilly Toxicogenomic Collaboration • Lilly-Roche-Regenstrief Institute Type 2 Diabetes Collaboration • ISDH-MPH-IBRI-IHIE Obesity State-wide Prevalence and Data Availability |
|
| Future Focus | • Building a population-diverse diabetes data set integrated with SdoH, biology, and digital data (wearables, CGSM…) to drive research and innovation. • Working on specific public-health projects where data integration/exchange and evaluation are critical components to success. |
|
| Talent Development | • Community-outreach in neighboring areas to 16Tech (High School) • Summer HS and College Intern Research Programs • Research partnerships with academic partners (college, graduate school) |
|
| Data Sharing Agreements | Many agreements in place; however, they are use case specific: • Regenstrief Institute • MPH (in process) • Indiana Health Information Exchange • IPHCA (in discussion) • Indiana University Health • PCORI CAPriCORN (Chicago-area) • Eli Lilly and Company • FUSE by Cardinal Health • …dozens of additional one-to-one relationships |
|
| Programs/ Publications | Annual report: https://www.indianabiosciences.org/annual-reports/ | |